Aleksandra Petrovic Fabijan
Alex completed her PhD in microbiology at The University of Novi Sad in 2016 as part of the Hungary-Serbia IPA Cross-Border Cooperation Programme (European Commission HUSRB 1203/214/250). She then moved to Australia to continue her postdoctoral career working under supervision of Prof. Jonathan Iredell. Since 2018, Alex’s has been studying phage and their biology and specifically investigating bacteria-bacteriophage interaction and host response in critically ill patients receiving adjunctive phage therapy. She worked as main phage biologist in world first-in-human clinical trial of intravenous GMP-grade phage therapy in septic patients and her recent work appears in leading scientific and medical journals (e.g. Nature Microbiology and Annals of Internal Medicine). Her current research is focused on bacterial cell and phage biology, specifically interactions between cell wall-deficient bacteria and phages and their implications in both antibiotic and phage therapy.
Abstracts this author is presenting: